Ligand Pharmaceuticals Incorporated Contingent Value Rights (LGNYZ)
Market Open
7 Jan, 20:51
OTC PINK OTC PINK Primary $
0. 04
-0.01
-17.7778%
$
741.52K Market Cap
- P/E Ratio
- Div Yield
4,973 Volume
0 Eps
$ 0.04
Previous Close Want to track LGNYZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ligand Pharmaceuticals Incorporated Contingent Value Rights (LGNYZ) Statistics
Valuation metrics
Market Cap 741.52K
Enterprise value -230.42M
Trailing P/E (ttm) 0
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0
Price/Book (mrq) 0
Enterprise Value/Revenue -0.79
Enterprise Value/EBITDA -1.4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 886.97K
Average volume (90 days) 304.72K
Price summary
52-Week low 0.04
52-Week high 0.04
Beta -
50-Day moving average 0.05
200-Day moving average 0.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0
Trailing annual dividend yield 0.0895%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Jul 2026
Ex-Dividend Date 26 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.68%
Operating margin 0.34%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.48
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 9.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 85.17
Total debt (mrq) -
Total Debt/Equity (mrq) 1.16
Current ratio (mrq) 30.49%
Book value per share (mrq) 48.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
